There is a paucity of data evaluating recurrence rates after breast conservation versus unilateral or bilateral mastectomy in CHEK2 carriers with BC, although some studies have suggested a higher risk of contralateral BC [32, 50, 51]. This evidence concerns the gene CHEK2 and breast cancer.